Adolescent Chicken Immune System Not Mature Enough for Vaccine
New University of Liverpool research reveals that the immune response of farmed chickens does not develop fast enough to fight off Campylobacter during their short lifespan. The findings have important implications in the challenge towards developing a poultry vaccine for the bug, which is the UK’s leading cause of food poisoning.
As both a public health and animal welfare issue, finding a way to control Campylobacter infection is a priority for the poultry industry. There are currently no commercial vaccines and their development is hampered by poor understanding of the immunobiology of the infection.
First study of its kind
In the first study of functional immunity to Campylobacter jejuni in the chicken, researchers have shown that antibody production plays a role, albeit limited, in the clearance of intestinal infection. However, it fails to clear the bacterium within the lifetime of a commercial broiler chicken, which is typically around six weeks of age.
Professor Paul Wigley, from the University’s Institute of Infection and Global Health, said: “Our findings suggest that any Campylobacter vaccine relying solely on an antibody response is unlikely to be effective in broiler chickens.”
Researchers carried out the study by chemically inhibiting the production of antibody-producing white blood cells (B lymphocytes) in broiler chicks, before introducing C.jejuni infection at the age of three weeks and then monitoring bacteria levels in the gut for the next nine weeks. They found that an antibody-associated drop in bacteria levels only became apparent after seven weeks and suggest that the adaptive immune response in the gut only begins to mature at six weeks of age.
Professor Wigley added: “It’s likely to be very challenging to produce a protective immune response in broiler chickens before slaughter age, which is around six weeks of age.”
“Vaccines that focus on a cell-mediated immune response, or alternatively some way of speeding up the production of antibodies in broiler chickens, may offer more promising routes to controlling Campylobacter, and ultimately reducing the amount of contaminated chicken in our supermarkets.”
Approximately four in five cases of Campylobacter infection in the UK result from contaminated poultry – either through consumption of undercooked meat or through cross contamination in the kitchen. While good hygiene and thorough cooking can effectively prevent infection, there are still more than 280,000 cases in the UK and the cost to the economy is estimated at up to £900 million each year.
This article has been republished from materials provided by The University of Liverpool. Note: material may have been edited for length and content. For further information, please contact the cited source.
Lacharme-Lora, L., Chaloner, G., Gilroy, R., Humphrey, S., Gibbs, K., Jopson, S., Wright, E., Reid, W., Ketley, J., Humphrey, T., Williams, N., Rushton, S. and Wigley, P. (2017). B lymphocytes play a limited role in clearance of Campylobacter jejuni from the chicken intestinal tract. Scientific Reports. doi:10.1038/srep45090
360 New Disease Models Identified in Lab Mouse StudyNews
The research, which generated over 20 million pieces of data, has found 360 new disease models and provides 28,406 new descriptions of the genes’ effects on mouse biology and disease.READ MORE
LifeArc, Dstl and CDRD Collaborate to Identify Antibacterial Drug TargetsNews
Novel approach capitalises on commonality across pathogens.READ MORE
FDA to Fast Track Designation for Pfizer and Lilly's TanezumabNews
Global Phase 3 program is studying potential new treatment option for millions of people living with chronic pain associated with osteoarthritis and chronic low back pain.READ MORE